发明名称 |
A PHARMACEUTICAL COMPOSITION CONTAINING COMBINATIONS OF NICOTINAMIDE AND 5-AMINOSALICYLIC ACID FOR BENEFICIALLY INFLUENCING THE INTESTINAL MICROBIOTA AND/OR TREATING GASTROINTESTINAL INFLAMMATION |
摘要 |
The present invention relates to a new pharmaceutical composition containing a combination of 5-aminosalicylic acid and nicotinamide or related compounds. The combination is believed to beneficially influence the intestinal microbiota and/or reduce gastrointestinal inflammation. In certain embodiments, the pharmaceutical composition is partially or entirely released into the small intestine or large intestine. |
申请公布号 |
US2016317557(A1) |
申请公布日期 |
2016.11.03 |
申请号 |
US201415103406 |
申请日期 |
2014.12.12 |
申请人 |
CONAIRS RESEARCH INSTITUTE AG |
发明人 |
Watzig Georg;Seegert Dirk |
分类号 |
A61K31/606;A61K9/00;A61K31/455 |
主分类号 |
A61K31/606 |
代理机构 |
|
代理人 |
|
主权项 |
1. A pharmaceutical composition comprising a combination of 5-aminosalicylic acid or a prodrug thereof and one or more active substances selected from nicotinamide; a compound that converts in the body of an animal or human into nicotinamide; nicotinamide adenine dinucleotide (NAD); nicotinamide adenine dinucleotide phosphate (NADP); an intermediate in the biosynthesis of NAD or NADP. |
地址 |
Keil DE |